HIKAL Financial Statement Analysis
|
||
|
The Revenues of HIKAL have increased by 4.13% YoY .
The Earnings Per Share (EPS) of HIKAL has decreased by -51.15 % YoY. |
||
| REVENUES |
| OPERATING MARGIN |
| PROFIT AFTER TAX |
| EPS |
| ROCE |
HIKAL Last 5 Annual Financial Results
[BOM: 524735|NSE : HIKAL]
| Consolidated | Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 |
|---|---|---|---|---|---|
| Revenues | ₹2,023 Cr | ₹1,943 Cr | ₹1,720 Cr | ₹1,507 Cr | ₹1,590 Cr |
| Expenses | ₹1,766 Cr | ₹1,602 Cr | ₹1,398 Cr | ₹1,234 Cr | ₹1,291 Cr |
| Operating Profit (Excl OI) | ₹257 Cr | ₹341 Cr | ₹323 Cr | ₹273 Cr | ₹298 Cr |
| Other Income | ₹5.41 Cr | ₹4.89 Cr | ₹4.98 Cr | ₹3.70 Cr | ₹2.26 Cr |
| Interest | ₹48 Cr | ₹31 Cr | ₹36 Cr | ₹52 Cr | ₹58 Cr |
| Depreciation | ₹109 Cr | ₹96 Cr | ₹85 Cr | ₹82 Cr | ₹93 Cr |
| Profit Before Tax | ₹105 Cr | ₹219 Cr | ₹206 Cr | ₹127 Cr | ₹149 Cr |
| Profit After Tax | ₹78 Cr | ₹160 Cr | ₹133 Cr | ₹84 Cr | ₹103 Cr |
| Consolidated Net Profit | ₹78 Cr | ₹160 Cr | ₹133 Cr | ₹84 Cr | ₹103 Cr |
| Earnings Per Share (Rs) | ₹6.36 | ₹13.02 | ₹10.80 | ₹6.85 | ₹8.36 |
| PAT Margin (%) | 3.87 | 8.26 | 7.74 | 5.60 | 6.48 |
| ROE(%) | 7.12 | 16.04 | 15.22 | 10.74 | 14.46 |
| ROCE(%) | 8.47 | 15.21 | 16.15 | 12.44 | 15.25 |
| Total Debt/Equity(x) | 0.66 | 0.63 | 0.65 | 0.79 | 0.87 |
Key Financials |
||
| Market Cap | : | ₹ 3,843.9 Cr |
| Revenue (TTM) | : | ₹ 1,815.8 Cr |
| Net Profit(TTM) | : | ₹ 71.6 Cr |
| EPS (TTM) | : | ₹ 5.8 |
| P/E (TTM) | : | 53.7 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| HIKAL | -0.2% | -5% | -5.6% |
| SUN PHARMACEUTICAL INDUSTRIES | 3% | 2.3% | 68.2% |
| CIPLA | 2.5% | 0.4% | 71.7% |
| DR REDDYS LABORATORIES | -0.2% | -4.9% | 40.3% |
| ZYDUS LIFESCIENCES | 5% | 10.4% | 109.1% |
| DIVIS LABORATORIES | -1.6% | -7% | 23.8% |
| MANKIND PHARMA | NA | NA | NA |
| TORRENT PHARMACEUTICALS | 2.9% | -2.2% | 69% |
| LUPIN | 2.8% | 0% | 147.8% |
HIKAL Revenues
[BOM: 524735|NSE : HIKAL]
| Y-o-Y | 4.13 % |
| 5 Yr CAGR | 6.21 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2023 | ₹2,023 Cr | 4.13 | |
| Mar2022 | ₹1,943 Cr | 12.92 | |
| Mar2021 | ₹1,720 Cr | 14.14 | |
| Mar2020 | ₹1,507 Cr | -5.18 | |
| Mar2019 | ₹1,590 Cr | - | |
HIKAL Operating Profit
[BOM: 524735|NSE : HIKAL]
| Y-o-Y | -24.51 % |
| 5 Yr CAGR | -3.64 % |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2023 | ₹257 Cr | -24.51 | |
| Mar2022 | ₹341 Cr | 5.47 | |
| Mar2021 | ₹323 Cr | 18.20 | |
| Mar2020 | ₹273 Cr | -8.37 | |
| Mar2019 | ₹298 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | -27.50 % |
| 5 Yr CAGR | -9.26 % |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2023 | 12.71% | -27.50 | |
| Mar2022 | 17.53% | -6.61 | |
| Mar2021 | 18.77% | 3.59 | |
| Mar2020 | 18.12% | -3.36 | |
| Mar2019 | 18.75% | - | |
HIKAL Profit After Tax
[BOM: 524735|NSE : HIKAL]
| Y-o-Y | -51.16 % |
| 5 Yr CAGR | -6.62 % |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2023 | ₹78 Cr | -51.16 | |
| Mar2022 | ₹160 Cr | 20.55 | |
| Mar2021 | ₹133 Cr | 57.68 | |
| Mar2020 | ₹84 Cr | -18.08 | |
| Mar2019 | ₹103 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | -53.15 % |
| 5 Yr CAGR | -12.09 % |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2023 | 3.87 % | -53.15 | |
| Mar2022 | 8.26 % | 6.72 | |
| Mar2021 | 7.74 % | 38.21 | |
| Mar2020 | 5.6 % | -13.58 | |
| Mar2019 | 6.48 % | - | |
HIKAL Earnings Per Share (EPS)
[BOM: 524735|NSE : HIKAL]
| Y-o-Y | -51.15 % |
| 5 Yr CAGR | -6.61 % |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2023 | ₹6.36 | -51.15 | |
| Mar2022 | ₹13 | 20.56 | |
| Mar2021 | ₹11 | 57.66 | |
| Mar2020 | ₹6.85 | -18.06 | |
| Mar2019 | ₹8.36 | - | |
HIKAL Return on Capital Employed (ROCE)
[BOM: 524735|NSE : HIKAL]
| Y-o-Y | -44.31 % |
| 5 Yr CAGR | -13.67 % |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2023 | 8.47% | -44.31 | |
| Mar2022 | 15.21% | -5.82 | |
| Mar2021 | 16.15% | 29.82 | |
| Mar2020 | 12.44% | -18.43 | |
| Mar2019 | 15.25% | - | |
HIKAL Share Price vs Sensex
| Current Share Price | : | ₹311.8 |
| Current MarketCap | : | ₹ 3,843.9 Cr |
| Updated EOD on | : | Apr 24,2024 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| HIKAL | -0.2% |
-5% |
-5.6% |
| SENSEX | 1.3% |
2.6% |
24% |
HIKAL related INDICES
| BSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| S&P BSE SMALL CAP | 3.2% | 12.8% | 65.7% |
| S&P BSE MIDSMALLCAP | 2.4% | 10.7% | 64.9% |
| S&P BSE ALLCAP | 1.6% | 6% | 40.6% |
| S&P BSE HEALTHCARE | -0.2% | 3.7% | 52.1% |
No NSE index found
You may also like the below Video Courses
FAQ about HIKAL Financials
How the annual revenues of HIKAL have changed ?
The Revenues of HIKAL have increased by 4.13% YoY .
How the Earnings per Share (EPS) of HIKAL have changed?
The Earnings Per Share (EPS) of HIKAL has decreased by -51.15 % YoY .
Check out Intrinsic Value of Peers of HIKAL
Compare Stock Analytics of Peers of HIKAL
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs
